GB1511645A - Sickle cell anaemia treatment - Google Patents

Sickle cell anaemia treatment

Info

Publication number
GB1511645A
GB1511645A GB15999/74A GB1599974A GB1511645A GB 1511645 A GB1511645 A GB 1511645A GB 15999/74 A GB15999/74 A GB 15999/74A GB 1599974 A GB1599974 A GB 1599974A GB 1511645 A GB1511645 A GB 1511645A
Authority
GB
United Kingdom
Prior art keywords
sickle cell
cell anaemia
treatment
methyl
anaemia treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB15999/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IFE, University of
Original Assignee
IFE, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IFE, University of filed Critical IFE, University of
Priority to GB15999/74A priority Critical patent/GB1511645A/en
Priority to DE19752523108 priority patent/DE2523108A1/de
Priority to ZA00753364A priority patent/ZA753364B/xx
Priority to FR7516781A priority patent/FR2272647B1/fr
Priority to NL7506384A priority patent/NL7506384A/xx
Priority to MW32/75A priority patent/MW3275A1/xx
Priority to BE156931A priority patent/BE829756A/xx
Publication of GB1511645A publication Critical patent/GB1511645A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB15999/74A 1974-05-31 1974-05-31 Sickle cell anaemia treatment Expired GB1511645A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB15999/74A GB1511645A (en) 1974-05-31 1974-05-31 Sickle cell anaemia treatment
DE19752523108 DE2523108A1 (de) 1974-05-31 1975-05-24 Heilmittel gegen sichelzellenanaemie
ZA00753364A ZA753364B (en) 1974-05-31 1975-05-26 Sickle cell anaemia treatment
FR7516781A FR2272647B1 (cg-RX-API-DMAC7.html) 1974-05-31 1975-05-29
NL7506384A NL7506384A (nl) 1974-05-31 1975-05-29 Werkwijze ter bereiding van farmaceutische preparaten ter bestrijding van sikkelcellen- anaemie.
MW32/75A MW3275A1 (en) 1974-05-31 1975-05-29 Sickle cell anaemia treatment
BE156931A BE829756A (fr) 1974-05-31 1975-05-30 Traitement de l'anemie a hematies falciformes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15999/74A GB1511645A (en) 1974-05-31 1974-05-31 Sickle cell anaemia treatment

Publications (1)

Publication Number Publication Date
GB1511645A true GB1511645A (en) 1978-05-24

Family

ID=10069370

Family Applications (1)

Application Number Title Priority Date Filing Date
GB15999/74A Expired GB1511645A (en) 1974-05-31 1974-05-31 Sickle cell anaemia treatment

Country Status (7)

Country Link
BE (1) BE829756A (cg-RX-API-DMAC7.html)
DE (1) DE2523108A1 (cg-RX-API-DMAC7.html)
FR (1) FR2272647B1 (cg-RX-API-DMAC7.html)
GB (1) GB1511645A (cg-RX-API-DMAC7.html)
MW (1) MW3275A1 (cg-RX-API-DMAC7.html)
NL (1) NL7506384A (cg-RX-API-DMAC7.html)
ZA (1) ZA753364B (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410537A (en) 1979-06-29 1983-10-18 Burroughts Wellcome Co. Pharmaceutical ethers
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5843994A (en) * 1991-10-21 1998-12-01 The United States Of America As Represeneted By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5877213A (en) * 1991-10-21 1999-03-02 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for therapy and prevention of cancer, AIDS, and anemia

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550785B1 (fr) * 1983-08-18 1985-12-06 Sanofi Sa Nouvelles compositions a activite antimicrobienne contenant des derives de l'acide benzoique, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs
US5003055A (en) * 1987-09-25 1991-03-26 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus
EP0567613B1 (en) * 1991-10-21 2002-02-20 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Compositions for therapy and prevention of cancer

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410537A (en) 1979-06-29 1983-10-18 Burroughts Wellcome Co. Pharmaceutical ethers
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5635533A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Methods for inducing differentiation of a cell using phenyacetic acid and derivatives
US5654333A (en) * 1991-10-21 1997-08-05 The United States Of America As Represented By The Department Of Health And Human Services Methods for prevention of cancer using phenylacetic acids and derivatives thereof
US5661179A (en) * 1991-10-21 1997-08-26 The United States Of America As Represented By The Department Of Health And Human Services Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof
US5708025A (en) * 1991-10-21 1998-01-13 The United States Of America As Represented By The Department Of Health And Human Services Methods for promoting wound healing
US5712307A (en) * 1991-10-21 1998-01-27 The United States Of America As Represented By The Department Of Health And Human Services Methods of inducing the production of hemoglobin and treating pathologies associated with abnormal hemoglobin activity using phemylacetic acids and derivatives therof
US5843994A (en) * 1991-10-21 1998-12-01 The United States Of America As Represeneted By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5852056A (en) * 1991-10-21 1998-12-22 The United States Of America As Represented By The Department Of Health And Human Services Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
US5877213A (en) * 1991-10-21 1999-03-02 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for therapy and prevention of cancer, AIDS, and anemia
US5883124A (en) * 1991-10-21 1999-03-16 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer

Also Published As

Publication number Publication date
ZA753364B (en) 1976-05-26
FR2272647B1 (cg-RX-API-DMAC7.html) 1978-10-06
MW3275A1 (en) 1976-09-08
FR2272647A1 (cg-RX-API-DMAC7.html) 1975-12-26
BE829756A (fr) 1975-09-15
NL7506384A (nl) 1975-12-02
DE2523108A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
IE40858B1 (en) New benzimidazole derivatives,their preparation,and their use in affecting gastric acid secretion
HU173557B (hu) Sposob poluchenija 3-amino-indazol-karbonovojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
GB1515284A (en) Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
KR910018398A (ko) 3당류 유니트(unit)를 함유하는 탄수화물 유도체
ES468181A1 (es) Un procedimiento para obtener un antibiotico.
GB1473795A (en) Nonapeptide amides having hormonal activity
AU544923B2 (en) Peptides
ES8502709A1 (es) Procedimiento para la preparacion de 1-alquil-androsta-1,4-dien-3,17-dionas
IE42340L (en) 11,12-secoprostaglandins
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
ES446836A1 (es) Procedimiento para la produccion de portaobjetos previamentetenidos, mejorados, para la investigacion de la sangre.
PH14576A (en) 9-(3-(3,5-cis-dimethylpiperazino)prophyl)carrazole,salts and solvates thereof and pharmaceutical compositions containing same
GB1449397A (en) Sunscreen composition
WO1987000174A3 (fr) 1-o-phosphono-saccharides, leur procede de production et d'utilisation
IE42168L (en) 1-alpha-hydroxy and alkanoyloxy-steroids
JPS53149974A (en) Nn*44*22pyrazolee1111*arbonamide** ethyl**benzenesulfonyl*urea process for preparing same and medical composition containing same
GB1274809A (en) Evomonoside derivatives
GB1460872A (en) Spirane derivatives and their use as perfuming and flavouring agents
HU174882B (hu) Sposob poluchenija proizvodnykh 1,12-metanooksimetano-indolo-kvadratnaja skobka-2,3-a-kvadratnaja skobka zakryta-kinolizina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
JPS5473729A (en) Novel muramyldipeptide derivative
GB1504646A (en) Acyl cyanoguanidines
ES436058A1 (es) Procedimiento para preparar esteres de acidos pirimidin (2) il-tionofosforicos.
ES485784A1 (es) Procedimiento para la obtencion de esteres de hidrocortisona
SE7710337L (sv) Forfarande for framstellning av 9,11-halogenerade steroider

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee